Literature DB >> 4946263

Carbamyl phosphate mediated inhibition of the sickling of erythrocytes in vitro.

L M Kraus, A P Kraus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4946263

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  5 in total

1.  Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation.

Authors:  D A Deiderich; R C Trueworthy; P Gill; A M Cader; W E Larsen
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

2.  [Structure-function relationship in normal and abnormal hemoglobins (author's transl)].

Authors:  E Kleihauer
Journal:  Klin Wochenschr       Date:  1974-11-01

3.  Life span of carbamylated red cells in sickle cell anemia.

Authors:  P F Milner; S Charache
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

4.  Management of sickle-cell disease.

Authors:  J Stuart
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

5.  Noncovalent modification of deoxyhemoglobin S solubility and erythrocyte sickling.

Authors:  M R Waterman; K Yamaoka; L Dahm; J Taylor; G L Cottam
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.